Pipli 1.125gm Injection
Marketer
Alika Healthcare Pvt Ltd
Salt Composition
Piperacillin (1000mg) + Tazobactum (125mg)
Overview Pipli 1.125gm Injection
The dual-antibiotic Pipli 1.125gm Injection combats bacterial infections by eliminating microorganisms. Administered by healthcare providers only, dosage and frequency are determined by a physician based on individual health conditions. Strict adherence to prescribed usage is vital. Potential side effects may encompass nausea, vomiting, diarrhea, rash, and injection site reactions (pain, swelling, redness). Persistent or worsening side effects necessitate immediate medical attention. Prior to treatment, inform your doctor of any antibiotic allergies, liver, or kidney issues, as dose adjustments or alternative medications may be necessary. While generally safe under medical guidance, its use during pregnancy and breastfeeding requires physician oversight.
Uses of Pipli 1.125gm Injection
Infections caused by bacteria
Major Benefits of Pipli 1.125gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Pipli 1.125gm Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Pipli 1.125gm Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Pipli 1.125gm Injection works:
Pipli 1.125gm Injection unites Piperacillin, an antibiotic, with Tazobactum, a beta-lactamase inhibitor. Piperacillin combats bacterial growth by disrupting their protective cell wall synthesis. Tazobactum counters bacterial resistance mechanisms, thereby boosting Piperacillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Pipli 1.125gm Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Pipli 1.125gm Injection is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; the evidence from human studies, however, remains scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Pipli Injection (1.125gm) is considered safe for breastfeeding individuals. Research in humans indicates minimal drug transfer into breast milk, posing no discernible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Pipli 1.125gm Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
Exercise caution when administering Pipli 1.125gm Injection to individuals with renal impairment; dosage modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Pipli 1.125gm Injection in individuals with hepatic impairment appears to pose minimal risk. Current evidence indicates dose modification may not be necessary; however, medical advice is recommended.
What if you forget to take Pipli 1.125gm Injection :
Omit a scheduled Pipli 1.125gm Injection? Seek medical advice immediately.
Facts to Know About Pipli 1.125gm Injection
| Label | Value |
|---|---|
| Addictive | None. |
| Type of Medication | Drugs to combat infection |




